Journal Detail Information

1

Cite

Share

Progress on pharmacological research of cardioprotection by salidroside

Drug Evaluation Research.2017;40(1):125-132. doi:10.7501/j.issn.1674-6376.2017.01.025

By increasing the release of Ca2+ from sarcoplasmic reticulum in cardiomyocytes,salidroside elevates myocardial contraction,and by up-regulation of sarcoplasmic reticulum Ca2+-ATPase expression,and down-regulation ofcalcineurin expression to promote Ca2+ return to sarcoplasmic reticulum,salidroside obstructs Ca2+ overload-induced myocardial injury,and improves heart function.Salidroside inhibits lipid peroxidation,and increases activities of enzymatic antioxidants in heart tissue,and inhibits expression of inflammatory cytokines,and mitochondrial permeability transition pore opening,thus blocks myocardial apoptosis,by anti-oxidation and anti-inflammation;salidroside improves myocardial ischemia by up-regulation of hypoxia-inducible factor and vascular endothelial growth factor expression to promote angiogenesis in ischemic myocardium;salidroside improves respiratory function of mitochondria in myocardium by stimulating PGC-1 αt-NRF-1/NRF-2 signaling pathway to produce finally cardioprotective effect.These effects of salidroside are thought that are major mechanism of antagonizing cardiac injury induced by hypoxia,ischemia,ischemic-reperfusion,exhaustive exercise,chemicals,and biologic toxin.

2

Cite

Share

Omarigliptin: A new kind of long acting DPP-4 inhibitor

Hongnan CHEN ; Ying DENG ; Xiujuan GUO ; Guodong HUA

Drug Evaluation Research.2017;40(1):133-137. doi:10.7501/j.issn.1674-6376.2017.01.026

Diabetes is a kind of metabolic disease characterized by hyperglycemia The oral hypoglycemic agents used currently are required to take every day,which brings inconvenience to patients.Omarigliptin is a small molecule DPP-4 (depeptidyl peptidase-4) inhibitor.The drug is developed by the Merck Co,mainly for the treatment of type two diabetes.The drug only need to be taken once a week,so as to improve the patient's compliance and adherence,thereby improving the therapeutic effect.This article introduces the information of omarigliptin from the aspects of synthesis,pharmacology,pharmacokinetics,and clinical research,which provides valuable information for pharmaceutical workers.

3

Cite

Share

Advances in anti-inflammatory and anti-tumor effects of the main components of Curcumae Rhizoma

Zhimei ZHAO ; Lijie ZHANG ; Tian XIA ; Zhi XIAO

Drug Evaluation Research.2017;40(1):119-124. doi:10.7501/j.issn.1674-6376.2017.01.024

Curcumae Rhizoma comes from Curcuma genus,functional breaking blood stasis,detumescence and acesodyne for treatment of Zhengjia accumulation,amenorrhea,traumatic injury and bruising pain.Modem pharmacological studies have shown that the main monomer composition of zedoary turmeric has a good anti-inflammatory and anti-tumor effects.The main monomer composition of zedoary turmeric copies of curcumol,beta etemene,curcumin anti-inflammatory anti-tumor mechanism of review,provide the basis for the further research progress and clinical application of zedoary turmeric.

4

Cite

Share

Clinical observation of diosmin combined with nimesulide in treatment of traumatic synovitis of knee joint

Shaoming JIN

Drug Evaluation Research.2017;40(1):115-118. doi:10.7501/j.issn.1674-6376.2017.01.023

Objective To observe the clinical curative effect of diosmin combined with nimesulide in treatment of drugs for the traumatic synovitis ofin knee joint.Methods Sixty patients the People's Liberation Army 425 Hospital diagnosis standard and the requirements in this study were averagely and randomly divided into combination group,nimesulide group and diosmin group,the patients in combination group were given diosmin and nimesulide treatment,the patients in nimesulide group were given nimesulide treatment,diosmin group were given diosmin treatment.The course of treatment was 14 d.Then score knee joint VAS,AKS rating,and swelling degree in each group before and after the treatment.Results After treatment,the patients with knee joint swelling,pain degree are improved,the difference before and after treatment has statistical significance (P ＜ 0.05),meanwhile differences in the combination group were larger than the other two groups (P ＜ 0.05).Conclusion The drugs of nimesulide and diosmin for the treatment of traumatic synovitis respectively have certain effect,but the combined treatment curative effect is remarkable than used alone.Combination medication can be more obviously relieving the pain of patients and prevent disease progression,reduce inflammation which achieved a satisfactory therapeutic effect.

5

Cite

Share

Effect of trimetazidine combined with atorvastatin on cardiac function andlevel of hs-CRP, IL-6, and Fib in patients with coronary heart disease

Huan LI ; Wen WANG ; Yi YAN ; Fengjun JIAO

Drug Evaluation Research.2017;40(1):108-111. doi:10.7501/j.issn.1674-6376.2017.01.021

Objective To investigate the effect of trimetazidine combined with atorvastatin on cardiac function and the level of hs-CRP,IL-6,and Fib in patients with coronary heart disease.Methods Patients (120 cases) with coronary heart disease in the first people's Hospital of Xianyang City from January 2014 to January 2016 were selected and randomly divided into two groups.The observation group was treated with trimetazidine combined with atorvastatin,the control group was treated with trimetazidine,the curative effect,left ventricular ejection fraction,left ventricular diastolic end systolic diameter,left ventricular posterior wall thickness and serum hs-CRP,IL-6,and Fib levels were compared.Results The effective rate of observation group was 91.67％ (55/60),significantly higher than the control group 76.67％ (46/60) (P ＜ 0.05);The left ventricular ejection fraction,left ventricular end-diastolic diameter,and left ventricular posterior wall thickness of two groups were significantly improved (P ＜ 0.05),and the improvement of the observation group was significantly better than that of control group (P ＜ 0.05);The serum levels of hs-CRP,IL-6,and Fib were significantly lower (P ＜ 0.05),and the observation group was more obvious (P ＜ 0.05);The incidence of adverse reactions of two groups had no significant difference.Conclusion Trimetazidine combined with atorvastatin have high curative effect on coronary heart disease,and can improve cardiac function,significantly reduce the levels of hs-CRP,IL-6,and Fib,worth clinical promotion.

6

Cite

Share

Clinical efficacy and safety observation of bevacizumab combined with docetaxel in treatment of advanced cervix cancer

Weixia ZHANG ; Ting YANG ; Juanni LIU ; Fenxia LI ; Lei CHEN

Drug Evaluation Research.2017;40(1):100-103. doi:10.7501/j.issn.1674-6376.2017.01.019

Objective To explore the clinical efficacy and safety of bevacizumab combined with docetaxel in treatment of advanced cervix cancer.Methods Seventy-five patients with advanced cervix cancer accepted in our hospital from April 2011 to April 2016 were selected and divided into observation group with 43 cases and control group with 32 cases according to different treatment methods.Patients in control group were given docetaxel,and patients in observation group were combined with bevacizumab on the basis of control group.The clinical efficacy,adverse reactions,life quality and pharmacoeconomics of two groups were observed and compared.Results The total efficacy and clinical control rate of observation group were all higher than control group with statistically significance (P ＜ 0.05).The adverse reaction rate of two groups had no difference.Total efficacy of life quality improvement was 83.72％,which was obviously higher than control group 62.50％ with statistically significance (P ＜ 0.05).The average cost of observation group was (83 ± 10) thousands,of control group was (18± 6) thousands.The cost of observation group was obviously higher than control group with statistically significance (P ＜ 0.05).Conclusion Using bevacizumab combined with docetaxel in treatment of advanced cervix cancer has better effect clinical but costs much than docetaxel.We should set on treatment according to patients' own situation.

7

Cite

Share

Efficacy of butylphthalide on elderly patients with acute cerebral infarction and its effect on serum uric acid, c-reactive protein, and hemorheology

Fengzhu MENG ; Kai WEN ; Hua GAO ; Xuemei LIN ; Fang WANG

Drug Evaluation Research.2017;40(1):96-99. doi:10.7501/j.issn.1674-6376.2017.01.018

Objective To investigate the efficacy of butylphthalide on elderly patients with acute cerebral infarction and its effect on serum uric acid,c-reactive protein,and hemorheology.Methods Elderly patients (86 cases) with acute cerebral infarction in Xi'an No.1 Hospital from January 2015 to December 2015 were randomly divided into two groups.The control group was treated with conventional symptomatic treatment of acute cerebral infarction,observation group added with butylphthalide soft capsules.The NIHSS score and efficacy of the two groups,the serum uric acid,c-reactive protein,and the change of hemorheology before and after treatment were compared.Results The effective rate of observation group was 90.70％,significantly higher than that of control group 72.09％ (P ＜ 0.05);The NIHSS score,serum uric acid and c-reactive protein levels,blood viscosity and platelet aggregation rate of two groups after treatment were significantly lower (P ＜ 0.05),the Barthel index were significantly increased (P ＜ 0.05),and the change of observation group were more significant (P ＜ 0.05).Conclusion Butylphthalide has high curative effect on elderly patients with acute cerebral infarction,can reduce the level of serum uric acid,c-reactive protein and the degree of nerve function defect,improve the hemorheology and life self-care activities ability,which can protect the brain.

8

Cite

Share

Clinical effect and safety of levosimendan, milrinone, and dobutamine in treatment of patients with ADHF

Lei WANG

Drug Evaluation Research.2017;40(1):92-95. doi:10.7501/j.issn.1674-6376.2017.01.017

Objective To explore the clinical effect and safety of levosimendan,milrinone,and dobutamine in treatment of patients with ADHF.Methods All 336 patients with ADHF accepted in Xi'an Center Hospital from April 2013 to April 2016 were selected and divided into group A,B,and C with 112 cases in each group.Patients in three groups were given levosimendan,milrinone,and dobutamine respectively.Then the clinical effect,hemodynamics,serum indexes,and safety of two groups were observed and compared.Results The total efficacy of group A (90.18％) was obviously higher than group B (58.93％) and group C (65.18％) with statistically significance (P ＜ 0.05).PCWP,PAMP,RAP,and SVR of three groups after treatment were lower than before (P ＜ 0.05).And PCWP,PAMP,and SVR of group A were obviously lower than those of group B and C (P ＜ 0.05).RAP among three groups after treatment had no difference.NT-proBNP,ET-1,and NE of three groups after treatment were lower than before (P ＜ 0.05),and group A was obviously lower than group B and C (P ＜ 0.05).Adverse reaction rate of group A was obviously lower than that of group B and C with statistically difference (P ＜ 0.05).Conclusion Levosimendan has better effect and safety than milrinone and dobutamine in treatment of patients with ADHF,which is worth clinical application.

9

Cite

Share

Comparison of effect of cisplatin or nedaplatin combined with paclitaxel as an adjuvant chemotherapy for cervical cancer

Yanfang ZHAO ; Shihui WANG ; Yuliang ZOU

Drug Evaluation Research.2017;40(1):87-91. doi:10.7501/j.issn.1674-6376.2017.01.016

Objective To compare the effect of cisplatin or nedaplatin combined with paclitaxel as an adjuvant chemotherapy for cervical cancer.Methods Total 160 patients with cervical cancer in Ningqiang County Tianjin Hospital from February 2011 to December 2015 were divided into two groups according to different treatments.Cisplatin group was treated with TP chemotherapy,nedaplatin group was treated with TN chemotherapy,the curative effect,adverse reaction of chemotherapy,hospitalization time and treatment costs were compared between the two groups.Results The effective rate of cisplatin group was 79.26％ and nedaplatin group's was 82.05％,the two groups had no significant difference;The incidence of Ⅰ-Ⅳ grade hemoglobin,leukocyte of nedaplatin group were significantly higher than those in the cisplatin group (P ＜ 0.05),but between the two groups Ⅲ and Ⅳ grade had no significant difference,the incidence of Ⅰ-Ⅳ grade and Ⅲ-Ⅳ grade nausea,vomiting of nedaplatin group were significantly lower than cisplatin group (P ＜ 0.05);The hospitalization time of nedaplatin group was significantly shorter than cisplatin group (P ＜ 0.05),The cost of treatment between nedaplatin group and cisplatin group had no significant difference.Conclusion Cisplatin or nedaplatin combined with paclitaxel has similar efficacy in the neoadjuvant chemotherapy for cervical cancer,gastrointestinal adverse reactions of nedaplatin are lower than cisptatin,bone marrow suppression increase but still can be controlled,nedaplatin chemotherapy can shorten the duration of hospitalization,and hospitalization expenses were not significantly increased,which makes it more easily accepted by patients.

10

Cite

Share

Effect of natriuretic peptide on vascular endothelial function and inflammatory factors of patients with heart failure complicating myocardial infarction

Jin DONG ; Qun DANG

Drug Evaluation Research.2017;40(3):365-368. doi:10.7501/j.issn.1674-6376.2017.03.015

Objective To investigate the effect of natriuretic peptide on vascular endothelial function and inflammatory factors of patients with heart failure complicating myocardial infarction.Methods Two hundred and twenty-six patients with heart failure complicating myocardial infarction admitted into Hanzhong Central Hospital from March 2012 to March 2016 were randomly divided into experimental group (n =138) and control group (n =128).Patients in control group were treated with conventional drug,and patients in experimental group were treated with natriuretic peptide based on conventional drug treatment.The vascular endothelial function,contents of NO and eddthelin 1,and inflammatory factors including CRP,IL-6,and TNF-α were detected.Results After 2 weeks of treatment,the flow-mediated vasodilation (FMD) and NO in experimental group were remarkably higher than those in control group,and eddthelin 1 was significantly lower than those of control group (P ＜ 0.05).Additionally,CRP,IL-6,and TNF-α in experimental group were significantly lower than those in control group after treatment for 5 d (P ＜ 0.05).Conclusion Natriuretic peptide could improve the vascular endothelial function of patients with heart failure complicating myocardial infarction via increasing the content of NO and decreasing content of eddthelin 1,and was benefit to cardiac function by inhibiting release of inflammatory factors.

DISPLAY OPTIONS

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share